Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-16
2006-05-16
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S466000, C514S337000, C549S467000, C546S284100
Reexamination Certificate
active
07045545
ABSTRACT:
The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12are as described in the specification.
REFERENCES:
patent: WO 94 29290 (1994-12-01), None
patent: WO 97 08167 (1997-03-01), None
patent: WO 97 43272 (1997-11-01), None
Schulze-Alexandru, M. et al ‘Quasi-atomistic receptor surrogates for the 5-HT2A receptor: a 3D-QSAR study on hallucinogenic substances’ CA 132:202636 (2000).
Ellis, F. et al ‘Benzofurans and benzopyrans as chronobiological agents’ CA 128:22811 (1997).
Royer, R. et al ‘Benzofurans. L. Access to furoisoquinolines’ CA 78:71948 (1973).
Wolff, M C et al The discriminative stimulus properties of LY233708, a selective seratonin reuptake inhibitor, in the pigeon, Psychopharmacology, (1999) 146:275-279.
H. Ishii, et al. “Total Synthesis of Lemaireocereine” Chem. Pharm. vol. 40, No. 8, 1992, pgs 1993-1996, XP00887200 p. 1994.
R. Royer, et al. “Recherches Sur le benzofuranne. L.—Étude de voies d'accés aux furoisoquinoléines” Bull. Soc. Chim. Fr., No. 11, 1972,m pp. 4201-4208, XP000088692 table VI.
Schulze-Alexandru, M., et al., n “Quasi-atomistic receptor surrogates for the 5-HT2A receptor: a 3D-QSAR study on hallucinogenic substances” CA 132:202636 (2000).
Ellis, F., et al. “Benzofurans and benzopyrans as chronobiological agents” CA 128:22811 (1997).
Royer, R., et al. “Benzofurans, L. Access to furoisoquinolines” CA 78:71948 (1973).
Briner Karin
Burkhart Joseph Paul
Burkholder Timothy Paul
Fisher Matthew Joseph
Gritton William Harlan
Eli Lilly and Company
Owens Amelia A.
Tucker R. Craig
LandOfFree
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3602332